With a focus on finding a better way to manage employee pharmacy benefits, SmithRx is a pharmacy benefit management (PBM) company that aims to use technology to connect employers and health plan members to specialized programs for pharmaceutical coverage. It provides a platform for small businesses so they can gain transparency and alternative methods to deliver pharmacy benefits. As a result, SmithRX strives to enable employees to access medications that are affordable and easy to acquire while also trying to reduce overhead costs for employers. SmithRx was was founded by Jake Frenz in 2016 and is headquartered in San Francisco, CA.

Register for Details

For more details on financing and valuation for SmithRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about SmithRx

Forge green plus iconForge green minus icon

What is SmithRx's IPO price?

The IPO price for SmithRx will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in SmithRx?

SmithRx is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell SmithRx share pre-IPO?

If you own SmithRx pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is SmithRx a publicly traded company?

SmithRx is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was SmithRx founded?

SmithRx was founded in 2016.

Who are SmithRx's major investors?

Great Oaks Venture Capital
Blumberg Capital
Catapult VC
FourCities Capital
NextGen Venture Partners
Metaplanet Holdings
SciFi VC
Precursor Ventures
Presight Capital
MCVC Partners
W Ventures
Highbury Group
Updated on: Jan 30, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.